Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 1, 2007, Pages

  Usa, Kristie ^a   Singh, Ravinder J ^b   Netzel, Brian C ^b   Liu, Yong ^a   Raff, Hershel ^a,c   Liang, Mingyu ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MAYO CLINIC   (United States)

^c ST LUKE S MEDICAL CENTER   (United States)

Author keywords

11 hydroxysteroid dehydrogenase; Hypertension; Mass spectrometry; Microdialysis

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; CORTICOSTERONE; DEHYDROCORTICOSTERONE; 11-DEHYDROCORTICOSTERONE; DRUG DERIVATIVE; ENZYME INHIBITOR; POTASSIUM; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; HYPERTENSION; INTERSTITIAL FLUID; KIDNEY MEDULLA; LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; URINE; ANIMAL; BLOOD PRESSURE; CIRCADIAN RHYTHM; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CARBENOXOLONE; CIRCADIAN RHYTHM; CORTICOSTERONE; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY MEDULLA; MALE; MICRODIALYSIS; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM; TANDEM MASS SPECTROMETRY;

EID: 34548042789     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00484.2006     Document Type: Article

References (43)

1. Berndt TJ, Liang M, Tyce GM, Knox FG. Intrarenal serotonin, dopamine, and phosphate handling in remnant kidneys. Kidney Int 59: 625-630, 2001.
2. Brem AS, Bina RB, King TC, Morris DJ. Localization of 2 11beta-OH steroid dehydrogenase isoforms in aortic endothelial cells. Hypertension 31: 459-462, 1998.
3. Brereton PS, van Driel RR, Suhaimi Fb Koyama K, Dilley R, Krozowski Z. Light and electron microscopy localization of the 11betahydroxysteroid dehydrogenase type I enzyme in the rat. Endocrinology 142: 1644-1651, 2001.
4. Bujalska I, Shimojo M, Howie A, Stewart PM. Human 11 betahydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue. Steroids 62: 77-82, 1997.
5. Castello R, Schwarting R, Muller C, Hierholzer K. Immunohistochemical localization of 11-hydroxysteroid dehydrogenase in rat kidney with monoclonal antibody. Renal Physiol Biochem 12: 320-327, 1989.
6. Choi S, Wong LS, Yamat C, Dallman MF. Hypothalamic ventromedial nuclei amplify circadian rhythms: do they contain a food-entrained endogenous oscillator? J Neurosci 18: 3843-3852, 1998.
7. Draper N, Stewart PM. 11beta-Hydroxysteroid dehydrogenase and the prereceptor regulation of corticosteroid hormone action. J Endocrinol 186: 251-271, 2005.
8. Escher G, Frey FJ, Frey BM. 11 beta-Hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney. Endocrinology 135: 101-106, 1994.
9. Escher G, Vogt B, Beck T, Guntern D, Frey BM, Frey FJ. Reduced 11beta-hydroxysteroid dehydrogenase activity in the remaining kidney following nephrectomy. Endocrinology 139: 1533-1539, 1998.
10. Fleshner M, Deak T, Spencer RL, Laudenslager ML, Watkins LR, Maier SF. A long-term increase in basal levels of corticosterone and a decrease in corticosteroid-binding globulin after acute stressor exposure. Endocrinology 136: 5336-5342, 1995.
11. Frey FJ. Impaired 11 beta-hydroxysteroid dehydrogenase contributes to renal sodium avidity in cirrhosis: hypothesis or fact? Hepatology 44: 795-801, 2006.
12. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988.
13. Gomez-Sanchez EP, Ganjam V, Chen YJ, Liu Y, Zhou MY, Toroslu C, Romero DG, Hughson MD, de Rodriguez A, Gomez-Sanchez CE. Regulation of 11 beta-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol. Am J Physiol Endocrinol Metab 285: E272-E279, 2003.
14. Han ES, Evans TR, Shu JH, Lee S, Nelson JF. Food restriction enhances endogenous and corticotropin-induced plasma elevations of free but not total corticosterone throughout life in rats. J Gerontol A Biol Sci Med Sci 56: B391-B397, 2001.
15. Hinojosa-Laborde C, Greene AS, Cowley AW Jr. Autoregulation of the systemic circulation in conscious rats. Hypertension 11: 685-691, 1988.
16. Kamermans M, Fahrenfort I, Schultz K, Janssen-Bienhold U, Sjoerdsma T, Weiler R. Hemichannel-mediated inhibition in the outer retina. Science 292: 1178-1180, 2001.
17. Knoll KE, Pietrusz JL, Liang M. Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiol Genomics 21: 222-229, 2005.
18. Krozowski Z, MaGuire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 80: 2203-2209, 1995.
19. Kyossev Z, Walker PD, Reeves WB. Immunolocalization of NAD-dependent 11 beta-hydroxysteroid dehydrogenase in human kidney and colon. Kidney Int 49: 271-281, 1996.
20. +-ATPase in opossum kidney cells. Am J Physiol Renal Physiol 277: F859-F865, 1999.
21. Liang M, Croatt AJ, Nath KA. Mechanisms underlying induction of heme oxygenase-1 by nitric oxide in renal tubular epithelial cells. Am J Physiol Renal Physiol 279: F728-F735, 2000.
22. Liang M, Berndt TJ, Knox FG. Mechanism underlying diuretic effect of L-NAME at a subpressor dose. Am J Physiol Renal Physiol 281: F414-F419, 2001.
23. Liang M, Yuan B, Rute E, Greene AS, Olivier M, Cowley AW Jr. Insights into Dahl salt-sensitive hypertension revealed by temporal patterns of renal medullary gene expression. Physiol Genomics 12: 229-237, 2003.
24. Liang M, Pietrusz JL. Thiol-related genes in diabetic complications. A novel protective role for endogenous thioredoxin 2. Arterioscler Thromb Vasc Biol 27: 77-83, 2007.
25. Liang M, Pietrusz JL. Distinct roles of 11β-hydroxysteroid dehydrogenase type 1 and type 2 in the regulation of endothelial nitric oxide synthase expression (Abstract). Hypertension 46: 3, 2005.
26. Linthorst AC, Flachskamm C, Barden N, Holsboer F, Reul JM. Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: an in vivo microdialysis study in transgenic mice. Eur J Neurosci 12: 283-291, 2000.
27. Mattson DL, Lu S, Nakanishi K, Papanek PE, Cowley AW Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol Heart Circ Physiol 266: H1918-H1926, 1994.
28. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 10: 394-399, 1995.
29. Nelson RE, Grebe SK, O'Kane DJ, Singh RJ. Liquid chromatographytandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem 50: 373-384, 2004.
30. Nishiyama A, Majid DS, Taher KA, Miyatake A, Navar LG. Relation between renal interstitial ATP concentrations and autoregulation-mediated changes in renal vascular resistance. Circ Res 86: 656-662, 2000.
31. Rundle SE, Funder JW, Lakshmi V, Monder C. The intrarenal localization of mineralocorticoid receptors and 11 beta-dehydrogenase: immunocytochemical studies. Endocrinology 125: 1700-1704, 1989.
32. Sandeep TC, Yau JL, MacLullich AM, Noble J, Deary IJ, Walker BR, Seckl JR. 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci USA 101: 6734-6739, 2004.
33. 2 production in conscious rats. J Clin Invest 97: 1978-1982, 1996.
34. Smith RE, Li KX, Andrews RK, Krozowski Z. Immunohistochemical and molecular characterization of the rat 11 beta-hydroxysteroid dehydrogenase type II enzyme. Endocrinology 138: 540-547, 1997.
35. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2: 821-824, 1987.
36. Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC, Whorwood CB. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet 347: 88-91, 1996.
37. 36a. Takeda Y, Inaba S, Furukawa K, Miyamori I. Renal 11β-hydroxysteroid dehydrogenase in genetically salt-sensitive hypertensive rats. Hypertension 32: 1077-1082, 1998.
38. Tannenbaum BM, Brindley DN, Tannenbaum GS, Dallman MF, McArthur MD, Meaney MJ. High-fat feeding alters both basal and stress-induced hypothalamic-pituitary-adrenal activity in the rat. Am J Physiol Endocrinol Metab 273: E1168-E1177, 1997.
39. Taylor NE, Glocka P, Liang M, Cowley AW Jr. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 47: 692-698, 2006.
40. Taylor RL, Machacek D, Singh RJ. Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol, and cortisone. Clin Chem 48: 1511-1519, 2002.
41. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM. 11beta-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25: 831-866, 2004.
42. White PC, Mune T, Agarwal AK. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18: 135-156, 1997.
43. Wilson RC, Harbison MD, Krozowski ZS, Funder JW, Shackleton CH, Hanauske-Abel HM, Wei JQ, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Licholai T, New MI. Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80: 3145-3150, 1995.